CELH
Celsius Holdings, Inc.
CELH has the edge over SJM overall, supported by stronger valuation and stronger modeled upside.
SJM
The J. M. Smucker Company
SJM has lower modeled downside risk, despite its lower overall score.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
SJM Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Weak |
SJM's profitability and cash flow are currently healthy, and its revenue is stable, but its balance sheet is weak.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH has the edge over SJM in the historical PE scenario, which offers more potential upside but is not a forecast.
SJM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 13x | $132 | — |
| Cheap | 16x | $33.38 | -75% |
| Fair | 20x | $42.33 | -68% |
| Expensive | 26x | $55.13 | -58% |
| Current | 62x | $132 | — |
Historical ranges are pointers, not guarantees.
SJM's PE is in its expensive range at 62x. If earnings grow as analysts expect, today's price would be 13x next year's earnings, in its cheap range.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
CELH has the edge over SJM on the outlook, with more favorable revenue expectations.
SJM Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Stable | |
| Improving | |
| Moderate | |
| High |
Analysts expect SJM's earnings to grow and its profitability to improve, with its revenue holding steady.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
SJM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $10.35 | +384% |
| Q3 2026 | $2.14 | +$15.86 |
| Q2 2026 | -$1.30 | +$10.27 |
| Q1 2026 | -$11.80 | -$9.40 |
| Q4 2025 | -$11.23 | -327% |
| Q3 2025 | -$13.72 | -294% |
| Q2 2025 | -$11.57 | -262% |
| Q1 2025 | -$2.40 | -$1.59 |
| Q4 2024 | $4.95 | +49400% |
SJM has the edge over CELH on earnings, with more consistent year-over-year improvement.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over SJM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH's operating margin was 20% last quarter, up 31 points from the same quarter a year ago.
SJM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.2B | +5% |
| Q2 2026 | $2.3B | +5.8% |
| Q1 2026 | $2.3B | +7% |
| Q4 2025 | $2.3B | +2.6% |
| Q3 2025 | $2.1B | -0.6% |
| Q2 2025 | $2.1B | -2.8% |
| Q1 2025 | $2.2B | -1.9% |
| Q4 2024 | $2.3B | +17% |
SJM's revenue has grown year over year for four quarters in a row: $2.2B last quarter, up 5% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | +21 points |
| Q2 2026 | 20% | +48 points |
| Q1 2026 | -23% | +3.7 points |
| Q4 2025 | 18% | +11 points |
| Q3 2025 | 2.2% | -14 points |
| Q2 2025 | -28% | -46 points |
| Q1 2025 | -27% | -41 points |
| Q4 2024 | 7.5% | -8 points |
SJM has the edge over CELH on profitability, with a higher operating margin.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
SJM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $337.3M | +$432.2M |
| Q2 2026 | $483.9M | +62% |
| Q1 2026 | $487M | +222% |
| Q4 2025 | $280.2M | -12% |
| Q3 2025 | -$94.9M | -293% |
| Q2 2025 | $298.9M | +0.5% |
| Q1 2025 | $151.3M | -39% |
| Q4 2024 | $317.2M | +1025% |
SJM has the edge over CELH on cash flow, with more consistent year-over-year improvement.
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has the edge over SJM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
SJM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +161K shares |
| 1 year | +0.1% | +138K shares |
| 3 years | +4.6% | +4.7M shares |
| 5 years | -1.2% | -1.3M shares |
| Available history | -5.8% | -6.6M shares |
SJM has 107M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5.7M |
| Q2 2026 | $400,000 |
| Q1 2026 | $200,000 |
| Q4 2025 | $400,000 |
| Q3 2025 | $4.6M |
| Q2 2025 | $200,000 |
| Q1 2025 | $400,000 |
| Q4 2024 | $100,000 |
SJM has spent almost nothing on buybacks in the past year.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has the edge over SJM on leverage, with a lower net debt burden relative to earnings.
SJM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.9x | High |
| Q2 2026 | 7.6x | High |
| Q1 2025 | 9.3x | High |
| Q4 2024 | 4.8x | High |
| Q3 2024 | 4.6x | High |
| Q2 2024 | 4.8x | High |
| Q1 2024 | 12.8x | High |
| Q4 2023 | 6.1x | High |
SJM's net debt is about 4.9 years of its operating earnings (EBITDA), up from 4.6 years a year ago.
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
SJM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 65.2 | Neutral |
| Stochastic | 74.3 | Neutral |
SJM's weekly RSI is 65 (neutral) and its Stochastic is 74 (neutral).
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH has the edge over SJM on valuation relative to its sector.
SJM PE vs Consumer Defensive Sector
| Metric | SJM | Sector median | Relative |
|---|---|---|---|
| PE | 62x | 19x | 216% above |
| PE % | 100 | 18 | 82 pts above |
SJM is trading at 62x earnings, a 216% premium to the Consumer Defensive sector's median of 19x.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
SJM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $126.0 | 4.6% above |
| 20 week MA | $122.7 | 7.4% above |
| 50 week MA | $110.9 | 19% above |
| 100 week MA | $109.7 | 20% above |
| 200 week MA | $119.3 | 10% above |
SJM has the edge over CELH on trend strength, trading above more of its moving averages.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.
SJM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $103.1 | $116.1 | +13% |
| 2021 | $116.1 | $133.0 | +15% |
| 2022 | $133.0 | $159.4 | +20% |
| 2023 | $159.4 | $126.4 | -21% |
| 2024 | $126.4 | $110.6 | -12% |
| 2025 | $110.6 | $99.7 | -9.9% |
| 2026 YTD | $99.7 | $131.7 | +32% |
SJM has the edge over CELH on returns for 2026, with the stronger performance.